Glucocorticoids are a mainstay in the treatment of many diseases, including
pulmonary and rheumatologic disorders. Unfortunately, as many as 90% of lo
ng-term glucocorticoid recipients lose a significant amount of bone and inc
ur an increased risk of fractures. This paper reviews the pathophysiology,
diagnosis, and treatment of glucocorticoid-induced osteoporosis.